Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;27(4):571-9.
doi: 10.1007/s00467-011-2037-0. Epub 2012 Jan 3.

Adenine phosphoribosyltransferase deficiency in children

Jérôme Harambat  1 , Guillaume Bollée, Michel Daudon, Irène Ceballos-Picot, Albert Bensman; APRT Study Group
Collaborators, Affiliations

Adenine phosphoribosyltransferase deficiency in children

Jérôme Harambat et al. Pediatr Nephrol. 2012 Apr.

Abstract

Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder characterized by 2,8-dihydroxyadenine (2,8-DHA) crystalluria that can cause nephrolithiasis and chronic kidney disease. The aim of our study was to assess the clinical presentation, diagnosis, and outcome of APRT deficiency in a large pediatric cohort. All pediatric cases of APRT deficiency confirmed at the same French reference laboratories between 1978 and 2010 were retrospectively reviewed. Twenty-one patients from 18 families were identified. The median age at diagnosis was 3 years. Diagnosis was made after one or more episodes of nephrolithiasis (17 patients), after urinary tract infection (1 patient), and by family screening (3 patients). The diagnosis was based on stone analysis and microscopic examination of urine and/or enzymatic determination of APRT on red blood cells. All children had null APRT enzyme activity in erythrocytes. APRT gene sequencing was performed on 18 patients, revealing six homozygous and 12 compound heterozygous mutations. At diagnosis, half of the patients had decreased kidney function, and two children presented with acute renal failure. Allopurinol treatment was given to all patients at a median dose of 9 mg/kg/day. After a median follow-up of 5 years, all patients showed stabilization or improvement of kidney function, normal growth and development, and six patients had recurrence of nephrolithiasis. Based on these results, we conclude that an excellent outcome can be achieved in children with APRT deficiency who receive the proper treatment.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Clin Invest. 1988 Mar;81(3):945-50 - PubMed
    1. Hum Genet. 1987 Feb;75(2):163-8 - PubMed
    1. Clin Chem. 2007 Apr;53(4):766-72 - PubMed
    1. Int J Urol. 1997 May;4(3):304-6 - PubMed
    1. Nephron Physiol. 2004;98(2):p31-6 - PubMed

Supplementary concepts

LinkOut - more resources